Trademark: 97636942
Word
PURACAP PHARMACEUTICAL
Status
Pending
Status Code
730
Status Date
Tuesday, April 30, 2024
Serial Number
97636942
Mark Type
3
Filing Date
Tuesday, October 18, 2022
Published for Opposition
Tuesday, September 12, 2023

Trademark Owner History
PuraCap Pharmaceutical LLC - Owner At Publication

Classifications
5 pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders
The mark consists of the word "PuraCap" over the word "PHARMACEUTICAL" and surrounded by an elliptical shape with its lower right-quadrant omitted.
Color is not claimed as a feature of the mark.
" PHARMACEUTICAL"

Trademark Events
Aug 4, 2023
Examiners Amendment -Written
Oct 21, 2022
New Application Entered
Nov 2, 2022
New Application Office Supplied Data Entered
Nov 4, 2022
Notice Of Design Search Code E-Mailed
Aug 1, 2023
Assigned To Examiner
Aug 4, 2023
Examiners Amendment E-Mailed
Aug 4, 2023
Notification Of Examiners Amendment E-Mailed
Aug 4, 2023
Examiner's Amendment Entered
Aug 7, 2023
Approved For Pub - Principal Register
Aug 23, 2023
Notification Of Notice Of Publication E-Mailed
Sep 12, 2023
Published For Opposition
Sep 12, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 30, 2024
Sou Extension 1 Granted
Apr 30, 2024
Sou Extension 1 Filed
Apr 30, 2024
Sou Teas Extension Received
May 1, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24